chr8-23114694-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000520607(ENSG00000284956):c.-38G>A variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00417 in 1,612,984 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0080 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 12 hom. )
Consequence
ENSG00000284956
ENST00000520607 5_prime_UTR_premature_start_codon_gain
ENST00000520607 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: -6.38
Genes affected
TNFRSF10C (HGNC:11906): (TNF receptor superfamily member 10c) The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 8-23114694-G-A is Benign according to our data. Variant chr8-23114694-G-A is described in ClinVar as [Benign]. Clinvar id is 709419.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00796 (1209/151836) while in subpopulation AFR AF= 0.0162 (665/41174). AF 95% confidence interval is 0.0151. There are 2 homozygotes in gnomad4. There are 588 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFRSF10C | NM_003841.5 | c.204G>A | p.Pro68Pro | synonymous_variant | 3/5 | ENST00000356864.4 | NP_003832.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENSG00000284956 | ENST00000520607 | c.-38G>A | 5_prime_UTR_premature_start_codon_gain_variant | 5/6 | 4 | ENSP00000493787.1 | ||||
TNFRSF10C | ENST00000356864.4 | c.204G>A | p.Pro68Pro | synonymous_variant | 3/5 | 1 | NM_003841.5 | ENSP00000349324.4 | ||
ENSG00000284956 | ENST00000520607 | c.-38G>A | 5_prime_UTR_variant | 5/6 | 4 | ENSP00000493787.1 |
Frequencies
GnomAD3 genomes AF: 0.00789 AC: 1197AN: 151720Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
1197
AN:
151720
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00272 AC: 685AN: 251482Hom.: 2 AF XY: 0.00274 AC XY: 373AN XY: 135916
GnomAD3 exomes
AF:
AC:
685
AN:
251482
Hom.:
AF XY:
AC XY:
373
AN XY:
135916
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00377 AC: 5512AN: 1461148Hom.: 12 Cov.: 30 AF XY: 0.00370 AC XY: 2686AN XY: 726792
GnomAD4 exome
AF:
AC:
5512
AN:
1461148
Hom.:
Cov.:
30
AF XY:
AC XY:
2686
AN XY:
726792
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00796 AC: 1209AN: 151836Hom.: 2 Cov.: 32 AF XY: 0.00792 AC XY: 588AN XY: 74254
GnomAD4 genome
AF:
AC:
1209
AN:
151836
Hom.:
Cov.:
32
AF XY:
AC XY:
588
AN XY:
74254
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 05, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at